Should more patients with acute ischaemic stroke receive thrombolytic treatment?

BMJ. 2009 Nov 11:339:b4584. doi: 10.1136/bmj.b4584.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomedical Research
  • Brain Ischemia / drug therapy*
  • Evidence-Based Medicine
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Secondary Prevention
  • Stroke / drug therapy*
  • Thrombolytic Therapy / statistics & numerical data
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator